Skip to main content

Lantern Pharma Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Lantern Pharma Inc

Did you know?

Capital expenditures decreased by 86% from FY24 to FY25.

Current Price

$2.23

+5.19%
Profile
Valuation (TTM)
Market Cap$24.94M
P/E-1.46
EV
P/B3.82
Shares Out11.18M
P/Sales
Revenue$0.00
EV/EBITDA

Lantern Pharma Inc (LTRN) Dividends

Dividend Overview

Dividend Yield

Dividend / Share

Key Metrics

Market Cap

$24.94M

P/E Ratio

-1.46

Forward P/E

EPS

$-1.57

PEG Ratio

0.04

Book Value

$0.58

Dividend Yield

Profit Margin

ROE

-262.00%

Dividend History

Dividend Safety

LTRN Dividend Analysis

Lantern Pharma Inc (LTRN) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -1.46. Free cash flow: $-15.68M. This page shows Lantern Pharma Inc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Lantern Pharma Inc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.